Managing Chronic Hepatitis C in Primary-Care Settings: More than Antiviral Therapy

Armstrong GL Wasley A Simard EP McQuillan GM Kuhnert WL Alter MJ . The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705–14.

Edlin BR Carden MR . Injection drug users: the overlooked core of the hepatitis C epidemic. Clin Infect Dis 2006; 42:673–6. Also available from: URL: http://www.journals.uchicago.edu/cgi-bin/resolve?id=doi:10.1086/499960 [cited 2007 Jan 3].

National Center for Health Statistics. Plan and operation of the third National Health and Nutrition Examination Survey, 1988-94. Vital Health Stat 1994; 1:1–416. Also available from: URL: http://www.cdc.gov/nchs/data/series/sr_01/sr01_032.pdf [cited 2007 Jan 3].

Glynn M Rhodes P . Estimated HIV prevalence in the United States at the end of 2003 National HIV Prevention Conference; 2005 Jun 12-15; Atlanta, Georgia. Abstract 595. Also available from: URL: http://www.aegis.com/conferences/NHIVPC/2005/T1-B1101.pdf [cited 2007 Jan 3].

Wasley A Finelli L Bell BP Alter MJ . The knowledge and behaviors of HCV-infected persons identified in a seroprevalence survey, United States, 2001–2002. Abstract [Poster 445] presented at 12th International Symposium on Viral Hepatitis And Liver Disease; 2006 Jul 1-5; Paris, France.

Poynard T Cacoub P Ratziu V Myers RP Dezailles MH Mercadier A . Fatigue in patients with chronic hepatitis C. J Viral Hepat 2002; 9:295–303.

Rodger AJ Jolley D Thompson SC Lanigan A Crofts N . The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999; 30:1299–301.

Hussain KB Fontana RJ Moyer CA Su GL Sneed-Pee N Lok AS . Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001; 96:2737–44.

Forton DM Taylor-Robinson SD Thomas HC . Reduced quality of life in hepatitis C—is it all in the head? J Hepatol 2002; 36:435–8.

Zickmund S Ho EY Masuda M Ippolito L LaBrecque DR . “They treated me like a leper.” Stigmatization and the quality of life of patients with hepatitis C. J Gen Intern Med 2003; 18:835–44.

Golden J Conroy RM O'Dwyer AM Golden D Hardouin JB . Illness-related stigma, mood and adjustment to illness in persons with hepatitis C. Soc Sci Med 2006; 63:3188–98.

Feld JJ Liang TJ . Hepatitis C—identifying patients with progressive liver injury. Hepatology 2006; 43:S194–206.

Heller T Seeff LB . Viral load as a predictor of progression of chronic hepatitis C? Hepatology 2005; 42:1261–3.

McHutchison JG Bartenschlager R Patel K Pawlotsky JM . The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice. J Hepatol 2006; 44:411–21.

Bruix J Sherman M ; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208–36.

O'Connell JJ Quick PD Zevin BD . Documenting disability: simple strategies for medical providers. Post PA , editor. Nashville (TN): Health Care for the Homeless Clinicians' Network, National Health Care for the Homeless Council, Inc.; 2004.

Sylvestre DL Loftis JM Hauser P Genser S Cesari H Borek N . Co-occurring hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. J Urban Health 2004; 81:719–34.

Schiff GD Kim S . Case management/multidisciplinary care models. In: King AM Wheeler MB Fernandez A Schillinger D Bindman A Grumbach K , editors. Medical management of vulnerable and underserved patients: principles, practice, and populations. New York: McGraw-Hill; 2007 p. 151–8.

McGinn TG Gardenier D McGinn LK Alfandre D O'Connor-Moore N Sturm TM . Treating chronic hepatitis C in the primary care setting. Semin Liver Dis 2005; 25:65–71.

Shehab TM Orrego M Chunduri R Lok AS . Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol 2003; 98:639–44.

Clark EC Yawn BP Galliher JM Temte JL Hickner J . Hepatitis C identification and management by family physicians. Fam Med 2005; 37:644–9.

Shehab TM Sonnad SS Lok AS . Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. J Viral Hepat 2001; 8:377–83.

Strader DB Wright T Thomas DL Seeff LB ; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39:1147–71.

Sarrazin C Teuber G Kokka R Rabenau H Zeuzem S . Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays. Hepatology 2000; 32:818–23.

Di Bisceglie AM George SL Mihindukulasuriya KL Hoffmann J Brunt EM Bacon BR . [Poster 337] Clinical, biochemical, virologic and histologic outcomes of chronic hepatitis C following sustained virologic response (SVR) to HCV therapy: a prospective 5 year cohort study. 57th Annual Meeting of the American Association for the Study of Liver Diseases; 2006 Oct 27-31; Boston, Massachusetts. Also available from: URL: http://www.posters2view.com/aasld06/view.php?nu=337 [cited 2007 Jan 3].

Hagan H Campbell J Thiede H Strathdee S Ouellet L Kapadia F . Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep 2006; 121:710–9.

Morrill JA Shrestha M Grant RW . Barriers to the treatment of hepatitis C. Patient, provider, and system factors. J Gen Intern Med 2005; 20:754–8.

Hagan H Latka MH Campbell JV Golub ET Garfein RS Thomas DA . Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. Clin Infect Dis 2006; 42:669–72.

Fishbein DA Lo Y Reinus JF Gourevitch MN Klein RS . Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr 2004; 37:1367–75.

Edlin BR Kresina TF Raymond DB Carden MR Gourevitch MN Rich JD . Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005; 40 Suppl 5:S276–85.

Arora S Thornton K Jenkusky SM Parish B Scaletti JV . Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico. Public Health Rep 2007; 122(Suppl 2):74–7.

Yozviak JL Vasiliadis E Kimmel SR Templer SJ Hoffman-Terry M . A survey of primary care residents regarding knowledge of hepatitis C. [Poster 254] 57th Annual Meeting of the American Association for the Study of Liver Diseases; 2006 Oct 27-31, Boston, Massachusetts. Also available from: URL: http://www.posters2view.com/aasld06/view.php?nu=254 [cited 2007 Jan 3].

Shepard CW Finelli L Alter MJ . Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5:558–67.

Ong JP Collantes R Pitts A Martin L Sheridan M Younossi ZM . High rates of uninsured among HCV-positive individuals. J Clin Gastroenterol 2005; 39:826–30.

Baldy LM Urbas C Harris JL Jones TS Reichert PE . Establishing a viral hepatitis prevention and control program: Florida's experience. Public Health Rep 2007; 122(Suppl 2):24–30.

Subiadur J Harris JL Rietmeijer CA . Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado. Public Health Rep 2007; 122(Suppl 2):12–7.

Heseltine G McFarlane J . Texas statewide hepatitis C counseling and testing, 2000-2005. Public Health Rep 2007; 122(Suppl 2):6–11.

Zimmerman R Finley C Rabins C McMahon K . Integrating viral hepatitis prevention into STD clinics in Illinois (excluding Chicago), 1999-2005. Public Health Rep 2007; 122(Suppl 2):18–23.

Zucker BL Hauser P . Integrated care models for HCV+ veterans with co-morbid psychiatric and substance-use disorders. National Viral Hepatitis Prevention Conference; 2005 Dec 5-9; Washington, DC.

Loftis JM Hauser P . Hepatitis C in patients with psychiatric disease and substance abuse: screening strategies and comanagement models of care. Curr Hepatitis Rep 2003; 2:93–100.

Health Resources and Services Administration (US). Ryan White CARE Act [cited 2006 Oct 20]. Available from: URL: http://hab.hrsa.gov/history.htm

Clanon KA Mueller JJ Harank M . Integrating treatment for hepatitis C virus infection into an HIV clinic. Clin Infect Dis 2005:40 (Suppl 5):S362–6.

Zevin B . Taking on hepatitis C in San Francisco. National Viral Hepatitis Prevention Conference; 2005 Dec 5-9; Washington, DC.

Rudman M . Taking on hepatitis C in Maryland. National Viral Hepatitis Prevention Conference; 2005 Dec 5-9; Washington, DC.

Grant WC Jhaveri RR McHutchison JG Schulman KA Kauf TL . Trends in health care resource use for hepatitis virus infection in the United States. Hepatology 2005; 42:1406–13. Also available from: URL: http://www.interscience.wiley.com/jpages/0270-9139/suppmat/index.html [cited 2007 Jan 3].

Health Resources and Services Administration (US). Education and Training: AIDS Education and Training Centers [cited 2006 Oct 20]. Available from: URL: http://hab.hrsa.gov/educating.htm